Autopsy report · NCT02234037

Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 months after it had already started.
Ran for about 2 years 6 months before it stopped.
3 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Emory University
Sponsor type: University, hospital or other
Conditions: Leukemia
Interventions: Decitabine; Exercise
Participants: 3
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.